BIOLINERX
Live / Allowed — Publication / registration review complete (as of 18 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 May 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 76760226
- Mark type
- Word mark
- Kind
- Service mark
- Register
- Principal
- Basis
- Use in commerce (§1(a))
- Filed
- 23 May 2023
- Published for opposition
- 08 Dec 2026
- Examining attorney
- Brandon Lozeau
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical product development services, namely, pharmaceutical product development through the discovery of compounds that helps for the treatment of a variety of diseases and symptoms; pharmaceutical product development services for a wide variety of diseases and symptoms, namely, neuropathic pain, bacterial infections, solid cancerous tumors; pharmaceutical product development services of new compounds for use in medicines for oncology patients; pharmaceutical research services; research and development services in the field of biotechnology
Owner
- BioLineRx Ltd., IL
Prosecution history
- 08 Nov 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Aug 2026 — ASSIGNED TO EXAMINER
- 20 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 May 2026 — REQUEST FOR TRANSFORMATION PROCESSED - TOTAL